通达信 DNA资金主力指标公式/资金生命线/主力筹码分布/主力成本

生命线反弹,主力资金开始进场,配合个股资金,个股趋势使用

image.png

    通达信副图指标公式:

    个股资金线:MA(C,1)/MA(REF(C,18),18)*100,LINETHICK2,COLOR00FFFF;

    资金生命线:MA(FORCAST(个股资金线,20),6),COLORBLUE,LINETHICK2;

    个股趋势A:=EXPMEMA(个股资金线,1),COLORCYAN,LINETHICK1;

    个股趋势:EXPMEMA(个股趋势A,5),COLORRED,LINETHICK2;

    升量:=个股资金线-个股趋势;

    跌量:=个股趋势-个股资金线;

    STICKLINE(升量>0,个股趋势,个股资金线,0.0,0),COLORRED;

    STICKLINE(跌量>0,个股资金线,个股趋势,0.0,0),COLORGREEN;

    SVOL:=INTPART(SUM(V,0)/CAPITAL);

    TJ0:=SVOL>REF(SVOL,1)ORBARSSINCE(CLOSE)=0;

    S1:=BARSLAST(TJ0)+1;

    TJ2:=S1<REF(S1,1);

    S2:=IF(TJ2,REF(S1,1)+1,S1);

    S3:=SUM(TJ2,0);

    ZK1:="KD.K#WEEK"(9,3,3);

    ZD2:="KD.D#WEEK"(9,3,3);

    ZF1:="MACD.DIF#WEEK"(12,26,9);

    ZA2:="MACD.DEA#WEEK"(12,26,9);

    换手:=V/CAPITAL*100,LINETHICK0;

    JCD:=FILTER(CROSS(ZK1,ZD2)ANDREF(ZD2,1)<30,13),NODRAW;

    取点:=BARSLAST(JCD);

    吸筹区:=IF(取点>0AND取点<61,取点,0);

    ZS1:=吸筹区;

    ZS2:=吸筹区+1;

    ZS3:=换手/5;

    ZSA:=IF(ZS1>0,SUM((ZS3),吸筹区+1),0),NODRAW;

    主筹码%:ZSA,NODRAW;

    获利%:EMA(WINNER(C)*100,2),NODRAW;

    建仓天数:ZS1,NODRAW;

    阶段总额(万):=SUM(AMOUNT/10000,S2)*100,NODRAW;

    阶段总量(手):=SUM(V,S2)*100,NODRAW;

    阶段成本:(阶段总额(万)/(阶段总量(手)/100)),COLORRED,NODRAW;

    P:=10;A:=5;

    N:=2.5;

    VAR2:=LLV(LOW,10);

    VAR3:=HHV(HIGH,25);

    卖出:=14.5*N,COLORC6C600;

    清仓:=17.5*N,COLORFF75FF;

    动力线:=(EMA((CLOSE-VAR2)/(VAR3-VAR2)*4,4)*10-17.5)*N;

    底部:=-15.5*N,COLOR70DB93;

    关注:=-12.5*N,COLORYELLOW;

    T1:=FILTER(CROSS(动力线,关注),20);

    T2:=FILTER(CROSS(动力线,底部),20);

    T3:=FILTER(CROSS(清仓,动力线),20);

    T4:=FILTER(CROSS(卖出,动力线),20);

    RSV:=((((HHV(HIGH,P)-CLOSE)/(HHV(HIGH,P)-LLV(LOW,P)))*200)-125);

    小股民:=SMA(RSV,A,1)+15,COLORGRAY,LINETHICK2;

    RSV1:=((((CLOSE-LLV(LOW,P))/(HHV(HIGH,P)-LLV(LOW,P)))*200)-105);

    主力:=SMA(RSV1,A,1)+15,COLORGRAY,LINETHICK2;

    起爆:=CROSS(主力,小股民),NODRAW;

    DRAWICON((T1ORT2),资金生命线,5);

    DRAWICON(起爆,资金生命线,15);

声明:本站所有文章,如无特殊说明或标注,均为本站原创发布。任何个人或组织,在未征得本站同意时,禁止复制、盗用、采集、发布本站内容到任何网站、书籍等各类媒体平台。如若本站内容侵犯了原著者的合法权益,可联系我们进行处理。